The Moov head lice treatment brand has experienced flat growth over the last 2 years. With over 90% of sales coming from pharmacies, where customers seek advice from pharmacists, it is important to define Moov's benefits over competitors. This will allow pharmacists to confidently recommend Moov to customers. The market is unpredictable and customers want a brand they can trust. The goal is to develop 5 new efficacy claims for Moov to increase its market share to 30% by June 2016. XPotential implemented a workshop bringing together different departments to develop new claims based on insights and the existing product. A new "Twice as effective" claim was identified and approved for new advertising.